Impact of Adjunctive Intravenous Iron Therapy on Hemoglobin Recovery in Obstetric Patients: A Retrospective Cohort Study
Journal of Clinical Medicine · 14.05.2026 · 15 (10) · 3766
DOI: 10.3390/jcm15103766 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 14.05.2026. Verfasst von Mihaela Ichim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, "Carol Davila" University of Medicine and Pharmacy, 8 Eroii Sanitari Blvd., 050474 Bucharest, Romania. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Postpartum anemia frequently requires packed red blood cell (PRBC) transfusion; however, the contribution of intravenous iron to early hematologic recovery remains uncertain. This study evaluated hemoglobin dynamics following transfusion and the effect of adjunctive intravenous iron therapy.
Methods
In this retrospective cohort study, 61 obstetric patients requiring PRBC transfusion were included. Hematologic parameters were assessed at admission, postoperatively, post-transfusion, and at day 7. Patients were stratified according to the administration of intravenous ferric carboxymaltose. Hemoglobin changes and reticulocyte response were analyzed, including a subgroup receiving two PRBC units.
Results
Mean hemoglobin decreased from 9.36 ± 1.16 g/dL at admission to 6.33 ± 1.05 g/dL postoperatively, increased to 8.32 ± 0.78 g/dL after transfusion, and reached 8.75 ± 0.97 g/dL at day 7 (p < 0.001). No significant differences between groups were observed before or immediately after transfusion. At day 7, hemoglobin was significantly higher in patients receiving intravenous iron compared with those without supplementation (9.63 ± 1.03 vs. 8.03 ± 0.36 g/dL, p < 0.001). The increase in hemoglobin from post-transfusion to day 7 was greater in the iron group (1.14 ± 0.84 vs. −0.15 ± 0.33 g/dL, p < 0.001), accompanied by a higher reticulocyte response (2.56 ± 0.49% vs. 0.93 ± 0.26%, p < 0.001). Similar findings were observed in the two-unit subgroup.
Conclusions
Adjunctive intravenous iron was associated with improved early hemoglobin recovery after transfusion without affecting immediate correction, supporting its clinical use in obstetric patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, "Carol Davila" University of Medicine and Pharmacy, 8 Eroii Sanitari Blvd., 050474 Bucharest, Romania.
- Department of Obstetrics and Gynecology, Elias University Emergency Hospital, 17 Mărăști Blvd., 050474 Bucharest, Romania.
Zitieren
APA
Ichim, M., Bot, M., Borislavschi, A., & Filipescu, A. (2026). Impact of Adjunctive Intravenous Iron Therapy on Hemoglobin Recovery in Obstetric Patients: A Retrospective Cohort Study. Journal of Clinical Medicine, 15(10), 3766. https://doi.org/10.3390/jcm15103766
Vancouver
Ichim M, Bot M, Borislavschi A, Filipescu A. Impact of Adjunctive Intravenous Iron Therapy on Hemoglobin Recovery in Obstetric Patients: A Retrospective Cohort Study. Journal of Clinical Medicine. 2026;15(10):3766. doi:10.3390/jcm15103766
BibTeX
@article{Ichim2026,
author = {Ichim, Mihaela and Bot, Mihaela and Borislavschi, Andreea and Filipescu, Alexandru},
title = {Impact of Adjunctive Intravenous Iron Therapy on Hemoglobin Recovery in Obstetric Patients: A Retrospective Cohort Study},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {10},
pages = {3766},
doi = {10.3390/jcm15103766}
}
EUVIMED